Insulet earnings were $302.8M for the trailing 12 months ending Mar 31, 2026, with -25.1% growth year over year. The latest PODD earnings report on Mar 31, 2026 announced Q1 2026 earnings of $91.1M, down 10.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PODD reported annual earnings of $247.1M, with -40.9% growth.
PODD past earnings growth
How has PODD's earnings growth performed historically?
On PODD's earnings call on Invalid Date, Insulet (NASDAQ: PODD) reported Q1 2026 earnings per share (EPS) of $1.30, up 160% year over year. Total PODD earnings for the quarter were $91.10 million. In the same quarter last year, Insulet's earnings per share (EPS) was $0.50.
As of the last Insulet earnings report, Insulet is currently profitable. Insulet's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $302.80 million, a 24.71% decrease year over year.
What was PODD's earnings growth in the past year?
As of Insulet's earnings date in Invalid Date, Insulet's earnings has grown -25.09% year over year. This is 35.68 percentage points lower than the US Medical Devices industry earnings growth rate of 10.59%. PODD earnings in the past year totalled $302.80 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.